RGLS
Regulus Therapeutics Inc.
10% owner Ali Behbahani bought $2.7M of Regulus Therapeutics Inc.
Bought$2,735,930
$0.62Price
4,398,602Shares
+214%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Ali Behbahani's record
5 other buys with 3 months of prices since 2018: on average −10.1% against the S&P 500, and 2 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Dec 4. Filed Mon, Dec 7, 5:09 PM ET, after the close. Not investment advice.